Deriugina E I, Olovnikova N I, Lemeneva L N, Belkina E V, Udalov G A, Chertkov I L
Gematol Transfuziol. 1991 Aug;36(8):11-6.
Human B-lymphoblastoid cell lines producing specific anti-D antibodies against Rh0(D) antigen have been established by EBV-transformation. The strong influence of the donor's immune status (serum titer of anti-D antibodies, intravenous booster injection prior to bleeding) is shown. The cell lines cloned by limiting dilution continuously produce anti-D antibodies in culture for 7 months or longer which is sufficient to support large-scale production of anti-D antibodies based on the cultivation of cryopreserved cells. Anti-D IgGl monoclonal antibodies obtained react with Rh-positive and Du cells but not with Rh-negative cells in serological tests. These human monoclonal antibodies could be useful in the prevention of Rh hemolytic disease of newborns.
通过EB病毒转化建立了产生针对Rh0(D)抗原的特异性抗-D抗体的人B淋巴细胞系。研究表明供体免疫状态(抗-D抗体血清滴度、采血前静脉加强注射)有很大影响。通过有限稀释克隆的细胞系在培养中连续7个月或更长时间产生抗-D抗体,这足以支持基于冷冻保存细胞培养的抗-D抗体大规模生产。所获得的抗-D IgG1单克隆抗体在血清学检测中与Rh阳性和Du细胞反应,但不与Rh阴性细胞反应。这些人源单克隆抗体可能有助于预防新生儿Rh溶血病。